ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CYNA Cynapsus Therapeutics Inc. (MM)

40.4805
0.00 (0.00%)
11 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cynapsus Therapeutics Inc. (MM) NASDAQ:CYNA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 40.4805 20.12 40.54 0 01:00:00

Cyngn to Present at the Cowen 2nd Annual Mobility Disruption Conference

23/02/2022 1:05pm

Business Wire


Cynapsus Therapeutics Inc. (NASDAQ:CYNA)
Historical Stock Chart


From Jun 2021 to Jun 2024

Click Here for more Cynapsus Therapeutics Inc. Charts.

Cyngn (or the “Company”) (NASDAQ: CYN), a developer of innovative autonomous driving software solutions for industrial and commercial enterprises, today announced that Lior Tal, CEO, Ben Landen, Vice President of Business Development, and Don Alvarez, CFO, are scheduled to present virtually at the Cowen 2nd Annual Mobility Disruption Conference on Thursday, March 3, 2022, at 1:30 p.m. PT/4:30 p.m. ET. The live webcast of the presentation can be accessed at the “Events & Presentations” page of Cyngn’s Investor Relations website by clicking here.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220219005006/en/

Cyngn management will present virtually at the upcoming Cowen Mobility Disruption Conference. Source: Cyngn

Management will also be participating in virtual one-on-one and small group meetings at the conference, which takes place March 2-4, 2022. Those interested in meeting with management may contact Cyngn’s Investor Relations representative listed below.

About Cyngn

Cyngn is an autonomous vehicle technology company that is focused on addressing industrial uses for autonomous vehicles. Cyngn believes that technological innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial industry challenges that exist today. These challenges include labor shortages, lagging technological advancements from incumbents, and high upfront investment requirements. Cyngn addresses these challenges with its Enterprise Autonomy Suite, which includes DriveMod (modular industrial vehicle autonomous driving software), Cyngn Insight (customer-facing software suite for monitoring/managing AV fleets and aggregating/analyzing data), and Cyngn Evolve (internal toolkit that enables Cyngn to leverage data from the field for artificial intelligence, simulation, and modeling).

To learn more, please visit https://cyngn.com/.

Carolyne Sohn Vice President, The Equity Group csohn@equityny.com (415) 568-2255

1 Year Cynapsus Therapeutics Inc. Chart

1 Year Cynapsus Therapeutics Inc. Chart

1 Month Cynapsus Therapeutics Inc. Chart

1 Month Cynapsus Therapeutics Inc. Chart